JD has 30 years of experience in the pharmaceutical, biotechnology and medical device industries. He has lead regulatory affairs groups in companies of all sizes but he has extensive experience in the start-up and virtual company environment. He has lead development efforts resulting in 4 product approvals including the most widely used myocardial perfusion imaging agent, a coronary vasodilator, a prostate cancer agent and a treatment for advanced emphysema plus has contributed significantly to the approval of another 5 products.
JD has built and lead regulatory affairs, quality assurance and clinical operations teams as well as been project lead on multiple successful cross-functional product development teams. He has successfully managed clinical trials in multiple therapeutic areas and established quality teams that have built out and/or refurbished several medical product manufacturing facilities.
JD earned a BS in Biochemistry from the University of Minnesota and a JD from Franklin Pierce Law Center (UNH).